Pedreros-Rosales, C.; Jara, A.; Lorca, E.; Mezzano, S.; Pecoits-Filho, R.; Herrera, P.
Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond. Toxins 2023, 15, 531.
https://doi.org/10.3390/toxins15090531
AMA Style
Pedreros-Rosales C, Jara A, Lorca E, Mezzano S, Pecoits-Filho R, Herrera P.
Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond. Toxins. 2023; 15(9):531.
https://doi.org/10.3390/toxins15090531
Chicago/Turabian Style
Pedreros-Rosales, Cristian, Aquiles Jara, Eduardo Lorca, Sergio Mezzano, Roberto Pecoits-Filho, and Patricia Herrera.
2023. "Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond" Toxins 15, no. 9: 531.
https://doi.org/10.3390/toxins15090531
APA Style
Pedreros-Rosales, C., Jara, A., Lorca, E., Mezzano, S., Pecoits-Filho, R., & Herrera, P.
(2023). Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond. Toxins, 15(9), 531.
https://doi.org/10.3390/toxins15090531
